Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

Cell

Volumn 159, Issue 1, 2014, Pages 80-93

  Sherman, Mara H ^a   Yu, Ruth T ^a   Engle, Dannielle D ^b   Ding, Ning ^a   Atkins, Annette R ^a   Tiriac, Herve ^b   Collisson, Eric A ^c   Connor, Frances ^d   Van Dyke, Terry ^e   Kozlov, Serguei ^f   Martin, Philip ^f   Tseng, Tiffany W ^a   Dawson, David W ^g   Donahue, Timothy R ^g   Masamune, Atsushi ^h   Shimosegawa, Tooru ^h   Apte, Minoti V ⁱ   Wilson, Jeremy S ⁱ   Ng, Beverly ^j,k   Lau, Sue Lynn ^j,l,m   Gunton, Jenny E ^j,k,l,m   Wahl, Geoffrey M ^a   Hunter, Tony ^a   Drebin, Jeffrey A ⁿ   O'Dwyer, Peter J ^o   Liddle, Christopher ^p   Tuveson, David A ^b   Downes, Michael ^a   Evans, Ronald M ^a,q   more..

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

^l University of Sydney   (Australia)

^m WESTMEAD HOSPITAL   (Australia)

ⁿ HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p WESTMEAD HOSPITAL   (Australia)

^q HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; GEMCITABINE; VITAMIN D RECEPTOR; ANTINEOPLASTIC AGENT; CALCITRIOL; CALCITRIOL RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PANCREATITIS; PROTEIN EXPRESSION; STROMA; TRANSCRIPTION REGULATION; TUMOR VOLUME; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CARCINOMA, PANCREATIC DUCTAL; DISEASE MODEL; GENE EXPRESSION PROFILING; METABOLISM; MOLECULAR GENETICS; PANCREATIC NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PANCREATITIS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 84907485104     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2014.08.007     Document Type: Article

References (72)

1. T. Aikawa, J. Gunn, S.M. Spong, S.J. Klaus, and M. Korc Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer Mol. Cancer Ther. 5 2006 1108 1116
2. D. Amakye, Z. Jagani, and M. Dorsch Unraveling the therapeutic potential of the Hedgehog pathway in cancer Nat. Med. 19 2013 1410 1422
3. M.V. Apte, and J.S. Wilson Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells J. Gastroenterol. Hepatol. 27 Suppl 2 2012 69 74
4. M.V. Apte, P.S. Haber, T.L. Applegate, I.D. Norton, G.W. McCaughan, M.A. Korsten, R.C. Pirola, and J.S. Wilson Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture Gut 43 1998 128 133
5. M.V. Apte, R.C. Pirola, and J.S. Wilson Pancreatic stellate cells: a starring role in normal and diseased pancreas Front Physiol 3 2012 344
6. J.M. Bailey, B.J. Swanson, T. Hamada, J.P. Eggers, P.K. Singh, T. Caffery, M.M. Ouellette, and M.A. Hollingsworth Sonic hedgehog promotes desmoplasia in pancreatic cancer Clin. Cancer Res. 14 2008 5995 6004
7. T.E. Bapiro, F.M. Richards, M.A. Goldgraben, K.P. Olive, B. Madhu, K.K. Frese, N. Cook, M.A. Jacobetz, D.M. Smith, and D.A. Tuveson A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy Cancer Chemother. Pharmacol. 68 2011 1243 1253
8. N. Bardeesy, A.J. Aguirre, G.C. Chu, K.H. Cheng, L.V. Lopez, A.F. Hezel, B. Feng, C. Brennan, R. Weissleder, and U. Mahmood Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse Proc. Natl. Acad. Sci. USA 103 2006 5947 5952
9. L.J. Bayne, G.L. Beatty, N. Jhala, C.E. Clark, A.D. Rhim, B.Z. Stanger, and R.H. Vonderheide Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer Cancer Cell 21 2012 822 835
10. G. Bergers, R. Brekken, G. McMahon, T.H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb, and D. Hanahan Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat. Cell Biol. 2 2000 737 744
11. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 2004 332 337
12. M.J. Bissell, and W.C. Hines Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nat. Med. 17 2011 320 329
13. H.A. Burris 3rd, M.J. Moore, J. Andersen, M.R. Green, M.L. Rothenberg, M.R. Modiano, M.C. Cripps, R.K. Portenoy, A.M. Storniolo, and P. Tarassoff Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J. Clin. Oncol. 15 1997 2403 2413
14. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc. Natl. Acad. Sci. USA 93 1996 7861 7864
15. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis J. Nutr. 128 1998 68 72
16. M.T. Cantorna, C. Munsick, C. Bemiss, and B.D. Mahon 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease J. Nutr. 130 2000 2648 2652
17. E.A. Collisson, A. Sadanandam, P. Olson, W.J. Gibb, M. Truitt, S. Gu, J. Cooc, J. Weinkle, G.E. Kim, and L. Jakkula Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Nat. Med. 17 2011 500 503
18. E.A. Collisson, C.L. Trejo, J.M. Silva, S. Gu, J.E. Korkola, L.M. Heiser, R.P. Charles, B.A. Rabinovich, B. Hann, and D. Dankort A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma Cancer Discov 2 2012 685 693
19. N. Ding, R.T. Yu, N. Subramaniam, M.H. Sherman, C. Wilson, R. Rao, M. Leblanc, S. Coulter, M. He, and C. Scott A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response Cell 153 2013 601 613
20. N.G. Dowell, and P.S. Tofts Fast, accurate, and precise mapping of the RF field in vivo using the 180 degrees signal null Magn. Reson. Med. 58 2007 622 630
21. C. Feig, A. Gopinathan, A. Neesse, D.S. Chan, N. Cook, and D.A. Tuveson The pancreas cancer microenvironment Clin. Cancer Res. 18 2012 4266 4276
22. A. Fukuda, S.C. Wang, J.P. Morris 4th, A.E. Folias, A. Liou, G.E. Kim, S. Akira, K.M. Boucher, M.A. Firpo, S.J. Mulvihill, and M. Hebrok Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression Cancer Cell 19 2011 441 455
23. I. Garrido-Laguna, M. Uson, N.V. Rajeshkumar, A.C. Tan, E. de Oliveira, C. Karikari, M.C. Villaroel, A. Salomon, G. Taylor, and R. Sharma Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer Clin. Cancer Res. 17 2011 5793 5800
24. V. Heinemann, M. Haas, and S. Boeck Systemic treatment of advanced pancreatic cancer Cancer Treat. Rev. 38 2012 843 853
25. S.R. Hingorani, L. Wang, A.S. Multani, C. Combs, T.B. Deramaudt, R.H. Hruban, A.K. Rustgi, S. Chang, and D.A. Tuveson Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Cancer Cell 7 2005 469 483
26. R.F. Hwang, T. Moore, T. Arumugam, V. Ramachandran, K.D. Amos, A. Rivera, B. Ji, D.B. Evans, and C.D. Logsdon Cancer-associated stromal fibroblasts promote pancreatic tumor progression Cancer Res. 68 2008 918 926
27. H. Ijichi, A. Chytil, A.E. Gorska, M.E. Aakre, B. Bierie, M. Tada, D. Mohri, K. Miyabayashi, Y. Asaoka, and S. Maeda Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma J. Clin. Invest. 121 2011 4106 4117
28. M.A. Jacobetz, D.S. Chan, A. Neesse, T.E. Bapiro, N. Cook, K.K. Frese, C. Feig, T. Nakagawa, M.E. Caldwell, and H.I. Zecchini Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer Gut 62 2013 112 120
29. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat. Rev. Cancer 6 2006 392 401
30. S. Kazerounian, K.O. Yee, and J. Lawler Thrombospondins in cancer Cell. Mol. Life Sci. 65 2008 700 712
31. T. Kisseleva, M. Cong, Y. Paik, D. Scholten, C. Jiang, C. Benner, K. Iwaisako, T. Moore-Morris, B. Scott, and H. Tsukamoto Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis Proc. Natl. Acad. Sci. USA 109 2012 9448 9453
32. J. Lawler Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth J. Cell. Mol. Med. 6 2002 1 12
33. M. Lesina, M.U. Kurkowski, K. Ludes, S. Rose-John, M. Treiber, G. Klöppel, A. Yoshimura, W. Reindl, B. Sipos, and S. Akira Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer Cancer Cell 19 2011 456 469
34. Y. Ma, B. Khalifa, Y.K. Yee, J. Lu, A. Memezawa, R.S. Savkur, Y. Yamamoto, S.R. Chintalacharuvu, K. Yamaoka, and K.R. Stayrook Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators J. Clin. Invest. 116 2006 892 904
35. D. Mahadevan, and D.D. Von Hoff Tumor-stroma interactions in pancreatic ductal adenocarcinoma Mol. Cancer Ther. 6 2007 1186 1197
36. S.T. Mann, H. Stracke, U. Lange, H.U. Klor, and J. Teichmann Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas Dig. Dis. Sci. 48 2003 533 538
37. T.S. Mantoni, S. Lunardi, O. Al-Assar, A. Masamune, and T.B. Brunner Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling Cancer Res. 71 2011 3453 3458
38. A. Masamune, and T. Shimosegawa Signal transduction in pancreatic stellate cells J. Gastroenterol. 44 2009 249 260
39. S. Nagpal, S. Na, and R. Rathnachalam Noncalcemic actions of vitamin D receptor ligands Endocr. Rev. 26 2005 662 687
40. T. Naveh-Many, and J. Silver Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression Endocrinology 133 1993 2724 2728
41. A. Neesse, K.K. Frese, T.E. Bapiro, T. Nakagawa, M.D. Sternlicht, T.W. Seeley, C. Pilarsky, D.I. Jodrell, S.M. Spong, and D.A. Tuveson CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer Proc. Natl. Acad. Sci. USA 2013 10.1073/pnas.1300415110 Published online July, 2013
42. K.P. Olive, M.A. Jacobetz, C.J. Davidson, A. Gopinathan, D. McIntyre, D. Honess, B. Madhu, M.A. Goldgraben, M.E. Caldwell, and D. Allard Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 2009 1457 1461
43. M.B. Omary, A. Lugea, A.W. Lowe, and S.J. Pandol The pancreatic stellate cell: a star on the rise in pancreatic diseases J. Clin. Invest. 117 2007 50 59
44. B.C. Ozdemir, T. Pentcheva-Hoang, J.L. Carstens, X. Zheng, C.C. Wu, T.R. Simpson, H. Laklai, H. Sugimoto, C. Kahlert, and S.V. Novitskiy Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival Cancer Cell 25 2014 719 734
45. K.S. Persons, V.J. Eddy, S. Chadid, R. Deoliveira, A.K. Saha, and R. Ray Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells Anticancer Res. 30 2010 1875 1880
46. P.A. Phillips, J.A. McCarroll, S. Park, M.J. Wu, R. Pirola, M. Korsten, J.S. Wilson, and M.V. Apte Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover Gut 52 2003 275 282
47. K. Pietras, and A. Ostman Hallmarks of cancer: interactions with the tumor stroma Exp. Cell Res. 316 2010 1324 1331
48. P.P. Provenzano, C. Cuevas, A.E. Chang, V.K. Goel, D.D. Von Hoff, and S.R. Hingorani Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma Cancer Cell 21 2012 418 429
49. Y. Pylayeva-Gupta, K.E. Lee, C.H. Hajdu, G. Miller, and D. Bar-Sagi Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia Cancer Cell 21 2012 836 847
50. L. Rahib, B.D. Smith, R. Aizenberg, A.B. Rosenzweig, J.M. Fleshman, and L.M. Matrisian Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res. 74 2014 2913 2921
51. K. Räsänen, and A. Vaheri Activation of fibroblasts in cancer stroma Exp. Cell Res. 316 2010 2713 2722
52. A.D. Rhim, P.E. Oberstein, D.H. Thomas, E.T. Mirek, C.F. Palermo, S.A. Sastra, E.N. Dekleva, T. Saunders, C.P. Becerra, and I.W. Tattersall Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma Cancer Cell 25 2014 725 737
53. E. Schneider, A. Schmid-Kotsas, J. Zhao, H. Weidenbach, R.M. Schmid, A. Menke, G. Adler, J. Waltenberger, A. Grünert, and M.G. Bachem Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells Am. J. Physiol. Cell Physiol. 281 2001 C532 C543
54. M. Shimoda, K.T. Mellody, and A. Orimo Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression Semin. Cell Dev. Biol. 21 2010 19 25
55. H.G. Skinner, D.S. Michaud, E. Giovannucci, W.C. Willett, G.A. Colditz, and C.S. Fuchs Vitamin D intake and the risk for pancreatic cancer in two cohort studies Cancer Epidemiol. Biomarkers Prev. 15 2006 1688 1695
56. R. Straussman, T. Morikawa, K. Shee, M. Barzily-Rokni, Z.R. Qian, J. Du, A. Davis, M.M. Mongare, J. Gould, and D.T. Frederick Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion Nature 487 2012 500 504
57. A. Vonlaufen, S. Joshi, C. Qu, P.A. Phillips, Z. Xu, N.R. Parker, C.S. Toi, R.C. Pirola, J.S. Wilson, D. Goldstein, and M.V. Apte Pancreatic stellate cells: partners in crime with pancreatic cancer cells Cancer Res. 68 2008 2085 2093
58. A.Y. Wehr, E.E. Furth, V. Sangar, I.A. Blair, and K.H. Yu Analysis of the human pancreatic stellate cell secreted proteome Pancreas 40 2011 557 566
59. S. Willemer, H.P. Elsässer, and G. Adler Hormone-induced pancreatitis Eur. Surg. Res. 24 Suppl 1 1992 29 39
60. T.R. Wilson, J. Fridlyand, Y. Yan, E. Penuel, L. Burton, E. Chan, J. Peng, E. Lin, Y. Wang, and J. Sosman Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Nature 487 2012 505 509
61. B.M. Wolpin, K. Ng, Y. Bao, P. Kraft, M.J. Stampfer, D.S. Michaud, J. Ma, J.E. Buring, H.D. Sesso, and I.M. Lee Plasma 25-hydroxyvitamin D and risk of pancreatic cancer Cancer Epidemiol. Biomarkers Prev. 21 2012 82 91
62. J. Yanagisawa, Y. Yanagi, Y. Masuhiro, M. Suzawa, M. Watanabe, K. Kashiwagi, T. Toriyabe, M. Kawabata, K. Miyazono, and S. Kato Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators Science 283 1999 1317 1321
63. T. Yoshizawa, Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T. Kawakami, K. Arioka, H. Sato, and Y. Uchiyama Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning Nat. Genet. 16 1997 391 396
64. W.D. Yu, Y. Ma, G. Flynn, J.R. Muindi, R.X. Kong, D.L. Trump, and C.S. Johnson Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system Cell Cycle 9 2010 3022 3029
65. U. Zeitz, K. Weber, D.W. Soegiarto, E. Wolf, R. Balling, and R.G. Erben Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor FASEB J. 17 2003 509 511
66. G.D. Barish, R.T. Yu, M. Karunasiri, C.B. Ocampo, J. Dixon, C. Benner, A.L. Dent, R.K. Tangirala, and R.M. Evans Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response Genes Dev. 24 2010 2760 2765
67. R.P. Sah, V. Dudeja, R.K. Dawra, and A.K. Saluja Cerulein-induced chronic pancreatitis does not require intra-acinar activation of trypsinogen in mice Gastroenterology 144 2013 1076 1085.e2
68. S. Schäfer, O. Zerbe, and A.M. Gressner The synthesis of proteoglycans in fat-storing cells of rat liver Hepatology 7 1987 680 687
69. M.H. Sherman, A.I. Kuraishy, C. Deshpande, J.S. Hong, N.A. Cacalano, R.A. Gatti, J.P. Manis, M.A. Damore, M. Pellegrini, and M.A. Teitell AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling Mol. Cell 39 2010 873 885
70. C. Trapnell, A. Roberts, L. Goff, G. Pertea, D. Kim, D.R. Kelley, H. Pimentel, S.L. Salzberg, J.L. Rinn, and L. Pachter Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks Nat. Protoc. 7 2012 562 578
71. M. Treiber, P. Neuhöfer, E. Anetsberger, H. Einwächter, M. Lesina, M. Rickmann, S. Liang, T. Kehl, H. Nakhai, R.M. Schmid, and H. Algül Myeloid, but not pancreatic, RelA/p65 is required for fibrosis in a mouse model of chronic pancreatitis Gastroenterology 141 2011 1473 1485 e1-e7
72. B.M. Yoo, T.Y. Oh, Y.B. Kim, M. Yeo, J.S. Lee, Y.J. Surh, B.O. Ahn, W.H. Kim, S. Sohn, J.H. Kim, and K.B. Hahm Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model Pancreatology 5 2005 165 176